Internal Medicine, Hematology & Oncology · Tulsa, OK
NPI
1538315676
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
11212 E 48th St
Tulsa, OK, 74146
Phone (918) 556-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
78,679 services
Medicare patients, 2024
271
Average age 71
Drug cost, 2024
$6.6M
1,574 prescriptions
Company payments, 2025
$41K
From 61 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hassan Kaleem was code J1437 (injection, ferric derisomaltose, 10 mg), 7,900 times for 68 patients. In total Hassan Kaleem billed 78,679 services in 82 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 7,900 | 68 | $15.76 | $125K |
| J0897 Injection, denosumab, 1 mg | Office | 2,340 | 11 | $20.96 | $49K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 794 | 29 | $0.09 | $70.19 |
| 99214 Office E&M - Established | Office | 611 | 164 | $95.36 | $58K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 520 | 14 | $0.70 | $365 |
| 99213 Office E&M - Established | Office | 237 | 136 | $62.89 | $15K |
| 96375 Injection Administration | Office | 150 | 34 | $11.37 | $1,706 |
| 96413 Chemotherapy Administration | Office | 145 | 28 | $93.24 | $14K |
| 96365 Intravenous Infusion, Hydration | Office | 140 | 89 | $45.29 | $6,340 |
| 96372 Injection Administration | Office | 117 | 24 | $10.60 | $1,240 |
| 36415 Venipuncture Blood Collection | Office | 83 | 40 | $8.26 | $686 |
| 99204 Office E&M - New | Office | 79 | 79 | $122.59 | $9,685 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 78 | 17 | $1.98 | $155 |
| 96366 Intravenous Infusion, Hydration | Office | 62 | 19 | $15.26 | $946 |
| 96367 Intravenous Infusion, Hydration | Office | 53 | 12 | $20.82 | $1,103 |
By year: 2022 $208K for 10,203 services; 2023 $1.2M for 59,040 services; 2024 $1.9M for 78,679 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 83 | 40 | $8.26 | $686 |
Medicare prescription drug claims, 2024
In 2024, the drug Hassan Kaleem prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 227 prescriptions and refills. In total Hassan Kaleem wrote 1,574 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 227 | 227 | 61 | $902K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 124 | 124 | 14 | $1.8M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 67 | 67 | 18 | $1,581 |
| Xarelto Rivaroxaban | 59 | 89 | 16 | $49K |
| Nivestym Filgrastim-Aafi | 58 | 58 | 16 | $170K |
| Eliquis Apixaban | 54 | 66 | 12 | $38K |
| Xtandi Enzalutamide | 41 | 41 | Under 11 | $565K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 37 | 37 | Under 11 | $1,392 |
| Promacta Eltrombopag Olamine | 35 | 35 | Under 11 | $353K |
| Ondansetron Odt Ondansetron | 34 | 34 | 25 | $382 |
| Tramadol Hcl Generic | 33 | 33 | 15 | $153 |
| Dexamethasone Generic | 31 | 31 | 15 | $664 |
| Pantoprazole Sodium Generic | 26 | 26 | Under 11 | $117 |
| Furosemide Generic | 25 | 34 | Under 11 | $80 |
| Prednisone Generic | 24 | 24 | 11 | $130 |
Brand drugs: 839 claims; generic drugs: 735 claims; opioid claims: 181.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hassan Kaleem $41K ($41K in general payments such as food, travel and fees) from 61 companies. The largest payer was Pharmacosmos Therapeutics Inc. with $35K.
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 50 | $35K |
| Pfizer Inc. PFE | 35 | $511 |
| Abbvie Inc. ABBV | 24 | $484 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $474 |
| Genzyme Corporation SNY | 12 | $328 |
| GlaxoSmithKline, LLC. GSK | 12 | $286 |
| Celgene Corporation BMY | 27 | $266 |
| Janssen Biotech, Inc. JNJ | 10 | $246 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $240 |
| Sobi, Inc SOBI.ST | 6 | $195 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.